Cytokinetics Inc (NAS:CYTK)
$ 84.88 -0.68 (-0.79%) Market Cap: 11.52 Bil Enterprise Value: 11.99 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Cytokinetics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 07:35 PM GMT
Release Date Price: $76.45 (+1.69%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CYTK.OQ - Cytokinetics Inc
Cytokinetics Inc at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 07:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Participant [1]
--------------------------------------------------------------------------------
All right. Thanks, everyone, for joining the team from Cytokinetics, represented by Isaac, who's their Chief Business Officer; Andrew, their Chief Commercial Officer; Dan, who's VP of Clinical Research and Executive Medical Director; and Sung Lee, their CFO. Thanks for being here.

=====================
Questions and Answers
--------------------------------------------------------------------------------
Unidentified Participant [1]
--------------------------------------------------------------------------------
A lot of exciting developments for the company over the past few months. Maybe we can start on the commercial side, actually. And one of the key investor debates
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot